companydata.dkNOVOZYMES BIOINDUSTRIAL CHINA A/S: Financial statements 2018
CVR: 21599042
NOVOZYMES BIOINDUSTRIAL CHINA A/S (CVR 21599042) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -67,702 and a net result of DKK -53,650 compared with DKK -57,773 the year before. Equity amounted to DKK 768,619,114. The solvency ratio was 100%.
- Gross Profit
- -67,702 kr.
- Profit/Loss
- -53,650 kr.
- Equity
- 768,619,114 kr.
- Total Assets
- 768,691,097 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -68 t. | -54 t. | 768.6 mio. | - |
| 2017 | - | -73 t. | -58 t. | 770.2 mio. | - |
| 2016 | - | -78 t. | -61 t. | 770.2 mio. | - |
| 2015 | - | -90 t. | -69 t. | 770.3 mio. | - |
Keep an eye on NOVOZYMES BIOINDUSTRIAL CHINA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2017. Gross profit came to DKK -73,105, and the net result was DKK -57,773.
About NOVOZYMES BIOINDUSTRIAL CHINA A/S
NOVOZYMES BIOINDUSTRIAL CHINA A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1999. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Lisbet Kragelund. The company is owned by NOVOZYMES A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 119,380,365 compared with DKK 394,633,084 the year before. Equity amounted to DKK 1,018,536,331.